Author

Matthew Alexander Lunning

University of Nebraska Medical CenterORCID 0000-0002-2761-7612Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genomics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:differential expression· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Julie Marie VoseiD· 4 shared Alyssa C. BouskaiD· 3 shared Javeed IqbaliD· 3 shared Timothy C. GreineriD· 3 shared Adnan MansooriD· 2 shared Dalia El‐GamaliD· 2 shared Dalia Y. MooreiD· 2 shared Douglas Allan StewartiD· 2 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Julie Marie VoseORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedNov 5, 2025

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Sunandini Sharma, Roshia Ali, Alyssa C. Bouska…·On behalf of the North American Mantle Cell Lymphoma Project (NAMCLP)

The paper identifies prognostic biological subtypes in Mantle cell lymphoma based on genetic and transcriptomic analysis, revealing distinct molecular and immune features associated with different risk groups.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJan 31, 2024

Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects

Alexandria P. Eiken, Audrey L. Smith, Sydney A. Skupa…·Dalia El-Gamal

This paper evaluates SpiD3, a novel spirocyclic dimer, showing potent anti-leukemic effects in CLL cells, including resistance to ibrutinib, by targeting NF-κB signaling and the UPR.

DOI 10.1158/2767-9764.crc-24-0071

humanmouse

𝕏 PostBluesky

GenomicsHaematologicaPeer-reviewedApr 1, 2021

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

Man Chun John Ma, Saber Tadros, Alyssa C. Bouska…·Michael R. Green

This study identifies subtype-specific and co-occurring genetic alterations across major B-NHL subtypes using targeted sequencing of 380 genes in 685 tumors.

74 citationstop 1%

humanwhole-exome sequencing

𝕏 PostBluesky

GenomicsScience Translational MedicinePeer-reviewedJun 19, 2019

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros…·Michael R. Green

The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.

64 citationstop 2%

humanwhole-genome sequencing

𝕏 PostBluesky